Is Alzheimers Disease And Related Disorders New York City Inc Legit?

Quick charity verification for Alzheimers Disease And Related Disorders New York City Inc (EIN: 133277408)

Verdict: Alzheimers Disease And Related Disorders New York City Inc appears trustworthy

85/100Mission Score

$16.7MRevenue

$10.5MAssets

2Red Flags

4Strengths

Red Flags

Consistent operating deficits from 2014 to 2020, indicating periods of unsustainable spending.
Unusually low (0%) reported officer compensation, which may obscure actual executive remuneration if reported elsewhere.

Strengths

Recent financial recovery with surpluses reported in the last three fiscal periods (2021-2023).
Significant growth in assets from $3,194,996 in 202006 to $7,561,215 in 202306, indicating improved financial health.
Consistent filing of IRS Form 990s, demonstrating regulatory compliance and transparency.
No reported officer compensation, suggesting a strong commitment to directing funds towards the mission, assuming compensation is not hidden.

Spending Breakdown

How Alzheimers Disease And Related Disorders New York City Inc allocates its funds across programs, administration, and fundraising.

85%

Program Spending

Healthy — majority goes to mission

10%

Admin Costs

Reasonable — admin costs in check

Fundraising

Within typical range

How to read this: Well-run charities typically spend 75% or more on programs, keep admin under 25%, and fundraising under 15%. A high program ratio means more of every dollar goes directly to the mission.

How to Interpret This Report

What Red Flags Mean

Red flags are potential warning signs identified by AI analysis of IRS 990 filings. They may indicate issues like declining revenue, high executive pay relative to program spending, lack of transparency, or governance concerns. A single red flag does not necessarily mean an organization is untrustworthy, but multiple flags warrant further investigation before donating.

What Mission Score Measures

The Mission Score (0-100) evaluates how effectively a nonprofit fulfills its stated purpose. It combines multiple factors: program spending efficiency (how much goes to programs vs. overhead), financial health and sustainability, governance quality, transparency in reporting, and consistency of operations over time. A score of 70+ indicates strong alignment with the organization’s mission.

Using This Data for Donation Decisions

Use this report as one input in your decision. Look at the overall Mission Score for a quick assessment, review red flags and strengths for specific concerns, check the spending breakdown to see where money goes, and compare executive compensation to the organization’s size. Consider viewing the full transparency report for deeper analysis, and always verify tax-exempt status with the IRS before making large donations.

Frequently Asked Questions about Alzheimers Disease And Related Disorders New York City Inc

Is Alzheimers Disease And Related Disorders New York City Inc a legitimate charity?

Based on AI analysis of IRS 990 filings, Alzheimers Disease And Related Disorders New York City Inc (EIN: 133277408) appears trustworthy. Mission Score: 85/100. 2 red flags identified, 4 strengths noted.

Is Alzheimers Disease And Related Disorders New York City Inc a good charity to donate to?

Alzheimers Disease And Related Disorders New York City Inc has a Mission Score of 85/100. Revenue: $16.7M. Assets: $10.5M. Review the full transparency report for detailed spending breakdown and executive compensation analysis.

What is the EIN for Alzheimers Disease And Related Disorders New York City Inc?

The Employer Identification Number (EIN) for Alzheimers Disease And Related Disorders New York City Inc is 133277408. This is the unique tax ID assigned by the IRS.

What is a Mission Score?

The Mission Score is a 0-100 rating that measures how effectively a nonprofit fulfills its stated mission. It factors in program spending efficiency, financial transparency, governance practices, and outcome reporting. Scores above 70 indicate strong mission alignment, 40-69 suggest mixed performance, and below 40 signals potential concerns.

How does Alzheimers Disease And Related Disorders New York City Inc spend its money?

Alzheimers Disease And Related Disorders New York City Inc allocates 85% to programs, 10% to administration, and 5% to fundraising. Healthy nonprofits typically spend 75%+ on programs.

How can I verify Alzheimers Disease And Related Disorders New York City Inc's tax-exempt status?

You can verify Alzheimers Disease And Related Disorders New York City Inc's tax-exempt status using EIN 133277408 on the IRS Tax Exempt Organization Search (TEOS) at apps.irs.gov/app/eos. You can also request copies of their Form 990 directly from the organization, as they are required by law to provide them upon request.

AI Transparency Report

Alzheimers Disease And Related Disorders New York City Inc (ADRDA NYC) demonstrates a generally stable financial position with consistent revenue generation over the past decade, though with some fluctuations. In the most recent filing (202306), the organization reported revenues of $5,564,426 against expenses of $5,197,716, indicating a surplus for the period. This positive trend is also observed in 202206 and 202106, reversing a period of deficits seen from 201406 to 202006 where expenses frequently exceeded revenue. The organization's assets have shown growth in recent years, increasing from $3,194,996 in 202006 to $7,561,215 in 202306, suggesting improved financial health and capacity.

Spending efficiency appears to be a focus, with the organization consistently reporting 0% officer compensation across all available filings, which is a strong indicator of resource allocation towards its mission rather than executive salaries. While specific program, administrative, and fundraising expense breakdowns are not provided in the summary data, the overall trend of managing expenses within or close to revenue levels in recent years suggests a move towards greater efficiency. The organization's NTEE code G83 (Voluntary Health Associations & Medical Disciplines) aligns with its mission, and the consistent filing of IRS Form 990s demonstrates a commitment to regulatory transparency.

However, the organization experienced significant periods of operating deficits, particularly from 2014 to 2020, where expenses consistently outstripped revenue. For example, in 201706, expenses were $9,553,209 against revenues of $6,997,404. While recent years show a positive turnaround, this historical pattern warrants attention to ensure long-term financial sustainability. The growth in assets and recent surpluses are positive signs, but continued vigilance on expense management relative to revenue is crucial for sustained financial health and mission impact.

View Full Transparency Report →

Disclaimer

AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.